[{"id":"ce910ebc-2111-40c9-8011-63c73b539176","acronym":"","url":"https://clinicaltrials.gov/study/NCT04898543","created_at":"2021-05-24T15:53:54.007Z","updated_at":"2024-07-02T16:35:22.660Z","phase":"Phase 1","brief_title":"QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors","source_id_and_acronym":"NCT04898543","lead_sponsor":"ImmunityBio, Inc.","biomarkers":" CD4 • NKG2D","pipe":"","alterations":" ","tags":["CD4 • NKG2D"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Anktiva (nogapendekin alfa inbakicept-pmln) • m-ceNK cells"],"overall_status":"Recruiting","enrollment":" Enrollment 50","initiation":"Initiation: 06/21/2021","start_date":" 06/21/2021","primary_txt":" Primary completion: 06/21/2024","primary_completion_date":" 06/21/2024","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2024-01-23"}]